• Home
  • About
    • Psychedelic For Healthy People
    • Psilocybin (Magic Mushrooms)
    • Ayahuasca (Chacruna – Kaapi – Yajé)
    • MDMA (MDA – Sassafras)
    • Peyote Mescaline (Huachuma)
    • Kambo – Amazonian Frog
    • 5-MeO-DMT (Toad Medicine)
    • Rapé And Sacred Tobacco
    • Iboga (Ibogaine)
    • LSD (Lysergic Acid Diethylamide)
    • Cannabis (Marijuana)
    • Ketamine
    • Psychedelic Integration
    • Psychedelics Advocates
    • Frequently Asked Questions
    • Mental Health Symptoms
    • Substances Test Kits
    • Manifesto
  • Treatments
    • Latest Psychedelic Research
    • Addiction
    • Alcoholism
    • Anxiety
    • Bipolar Disorder
    • Cancer
    • Cluster Headaches
    • Depression
    • End Of Life
    • OCD
    • Neuropathy
    • Pain
    • Parkinson’s Disease
    • PTSD
    • Smoking
    • Help Treat Mental Illness
  • Microdosing
    • What is Microdosing?
    • Microdosing Magic Mushrooms
    • Microdosing LSD
    • Microdosing MDMA
    • Microdosing Ayahuasca
    • Microdosing Mescaline
    • Microdosing Cannabis
    • Microdosing Ibogaine
  • Resources
    • Past Events
    • ALL Locations
    • DMT Psychoactive Plants
    • Medical Trials And Research
    • Psychedelic Research
    • EntheoPodcasts
    • In The News
    • Books On Psychedelics
    • Related Videos
    • EntheoResources
    • Terence McKenna
    • What Is Psychedelic Art?
    • Useful Links
    • Movies & Documentaries
    • Michael Pollan
Contact
  • Follow
  • Follow
  • Follow
  • Follow

This Will Change Your Mind About Psychedelic Drugs

by EmpathiCSubstanceS | May 17, 2018 | Addiction, Depression

For years, the field of mental health has been largely barren of meaningful treatment advances. But now, scientists have new hope in the least likely of places: psychedelic drugs. Recent research suggests that certain psychedelic substances can help relieve anxiety,...

Ketamine, notorious club drug, shows promise as a treatment for depression, studies indicate

by EmpathiCSubstanceS | May 14, 2018 | Anxiety

Sabrina Misra suffered from depression for most of her life, but last summer, it became almost too heavy to bear. Despite years of therapy and a trove of medications, Misra, 36, had become so despondent that she started planning her suicide. But before she acted, her...

Ketamine offers new hope for patients with severe depression

by EmpathiCSubstanceS | May 14, 2018 | Depression

Inspired by promising research into ketamine’s therapeutic effects, people are swapping strategies online on how to use the drug to ease their despair. Could ‘Special K’ be a panacea for depression? Wency Leung reports John woke up one morning...

The Long, Hard Road to a Science of Bad Drug Trips

by EmpathiCSubstanceS | May 14, 2018 | Anxiety, Depression

If we’re going to use psychedelics for therapy, we’re going to have to figure out the proverbial bad trip. This story is part of When the Drugs Hit, a Motherboard journey into the science, politics, and culture of today’s psychedelic renaissance. Follow along...

Ketamine Stirs up Hope—and Controversy—as a Depression Drug

by EmpathiCSubstanceS | May 9, 2018 | Addiction, Depression

The next big depression treatment might be ketamine, but how best to use it remains unknown. MICHAEL WAS ON the 55th floor of a high rise in an Asian capital, in a conference room, when his world cracked open. His heart began to race and the building felt as if it...
« Older Entries
Next Entries »

IMPORTANT NOTICE:

This community is being designed as a secure space. It is not a place to seek, encourage, or participate in the procurement of controlled substances. Do not bring, buy, sell, transfer, or arrive on any illegal substances, or swap information on how to buy them. Attendees and/or members of this community who violate these basic house rules will be removed from the community and will not be allowed to attend future events.

Psychedelic Research

Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study

Aug 11, 2022

Nonparametric comparisons via Friedman Test between baseline and 12-month follow-up for participants completing all interviews (n = 8) showed a significant reduction for the ASI-Lite drug use (p = 0.002) composite score. Reductions in BDI-II scores from baseline to...

Psychiatry’s next top model: Cause for a re-think on drug models of psychosis and other psychiatric disorders

Aug 11, 2022

In the first part, mental health professionals associated statements referring to specific experiences, for example 'I don't bother to get out of bed', to one or more psychiatric symptom clusters, for example depression and negative psychotic symptoms. This measured...

Effects of psilocybin therapy on personality structure

Aug 11, 2022

Neuroticism scores significantly decreased while Extraversion increased following psilocybin therapy. These changes were in the direction of the normative NEO‐PI‐R data and were both predicted, in an exploratory analysis, by the degree of insightfulness experienced...

Psychedelic Medicine

Principles to Make the Most of Your Psychedelic Experience: Set and Setting

Apr 13, 2020

When I recently had the opportunity to talk with a psychedelic integration specialist, we discussed all kinds of topics—addiction, anxiety, mindfulness, and, of course, psychedelic experiences. With several years under his belt as a recovery coach and integration...

How to Describe Your Psychedelic Experience Using Shulgin’s Rating Scale

Apr 13, 2020

Experienced psychonauts are aware of the fact that the psychedelic space can sometimes be tricky to navigate, and know that it is helpful to have techniques available to assist with that effort. Accurately identifying the intensity of an experience can help while the...

Who is Terence McKenna?

Apr 9, 2020

[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="dark" text_align="left" overlay_strength="0.3" shape_divider_position="bottom"][vc_column column_padding="no-extra-padding" column_padding_position="all"...

Psychedelic Law Reform

Apr 8, 2020

[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="dark" text_align="left" overlay_strength="0.3" shape_divider_position="bottom"][vc_column column_padding="no-extra-padding" column_padding_position="all"...

Psilocybin Initiative: Update on Implementation and Implication for Future Psychedelic Decriminalization Initiatives

Apr 8, 2020

[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="dark" text_align="left" overlay_strength="0.3" shape_divider_position="bottom"][vc_column column_padding="no-extra-padding" column_padding_position="all"...

© 2025| All Rights Reserved, EntheoMedicine Community
  • Follow
  • Follow
  • Follow
  • Follow